COCH Logo

Envoy Medical, Inc. (COCH) 

NASDAQ
Market Cap
$31.78M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
368 of 958
Rank in Industry
44 of 120

Largest Insider Buys in Sector

COCH Stock Price History Chart

COCH Stock Performance

About Envoy Medical, Inc.

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Insider Activity of Envoy Medical, Inc.

Over the last 12 months, insiders at Envoy Medical, Inc. have bought $22,219 and sold $0 worth of Envoy Medical, Inc. stock.

On average, over the past 5 years, insiders at Envoy Medical, Inc. have bought $6.34M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Patel Mona Chetan (director) — $22,219.

The last purchase of 2,500 shares for transaction amount of $5,699 was made by Patel Mona Chetan (director) on 2024‑11‑20.

List of Insider Buy and Sell Transactions, Envoy Medical, Inc.

2024-11-20Purchasedirector
2,500
0.0123%
$2.28$5,699+0.23%
2024-09-11Purchasedirector
4,000
0.0289%
$3.33$13,320-22.64%
2024-09-09Purchasedirector
1,000
0.0069%
$3.20$3,200-23.38%
2023-11-21PurchaseChief Executive Officer
12,380
0.026%
$0.97$11,990+158.76%
2023-11-20Purchase
100,000
$11.50$1.15M+151.00%
2023-09-29Purchase10 percent owner
1M
$11.50$11.5M-66.17%

Insider Historical Profitability

81.2%
Patel Mona Chetandirector
7500
0.037%
$1.5730
TAYLOR GLEN A
1100000
5.4335%
$1.5710+151%
Anzu SPAC GP I LLC10 percent owner
1000000
4.9395%
$1.5710<0.0001%
Lucas Brent T.Chief Executive Officer
120831
0.5968%
$1.5710+158.76%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.